Selective inhibition of anti-viral immune response to enhance the efficacy of oncolytic virotherapy
Selective inhibition of anti-viral immune response to enhance the efficacy of oncolytic virotherapy
选择性抑制抗病毒免疫反应以增强溶瘤病毒疗法的功效
批准号：
331490
负责人：
Kim Youra
金额：
$1.27万
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2014
资助国家：
加拿大
项目状态：
已结题
起止时间：
2014-12-01 至 2015-12-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
According to the Canadian Cancer Statistics 2014 Report, an estimated 191,300 Canadians will develop cancer this year and 76,600 are expected to succumb to the disease. Despite this large impact, effective treatment options are limited, so there is great
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Virus-induced Tumor MHC Ligandome Discovery for Cancer Immunotherapy
-
批准号：365527
-
项目类别：Studentship Programs
-
资助金额：$7.65万
-
财政年份：2016
-
负责人：Kim Youra
-
依托单位：
海外基金
